China has started the first phase of a clinical trial for a novel coronavirus vaccine, records show, as the world’s scientists race to find a way to combat the deadly pathogen.
It comes after US health officials said last week they had started a trial to evaluate a possible vaccine in Seattle.
The Chinese effort began on March 16 — the same day as the US announcement — and is expected to continue until the end of the year, according to a filing in the country’s Clinical Trial Registry, dated March 17.